Farzan M, Choe H, Vaca L, Martin K, Sun Y, Desjardins E, Ruffing N, Wu L, Wyatt R, Gerard N, Gerard C, Sodroski J
Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
J Virol. 1998 Feb;72(2):1160-4. doi: 10.1128/JVI.72.2.1160-1164.1998.
Human immunodeficiency virus type 1 (HIV-1) requires the presence of specific chemokine receptors in addition to CD4 to enter target cells. The chemokine receptor CCR5 is used by the macrophage-tropic strains of HIV-1 that predominate during the asymptomatic stages of infection. Here we identify a small tyrosine-rich region of CCR5 proximal to the N-terminal cysteine that is critical for entry of macrophage-tropic and dual-tropic variants of HIV-1. HIV-1 infection of cells expressing CCR5 mutants with changes in this region was substantially reduced compared with the infection of cells bearing wild-type CCR5. Simian immunodeficiency virus (SIVmac239) entry was also ablated on a subset of these mutants but enhanced on others. These differences in virus entry were correlated with the relative ability of soluble, monomeric HIV-1 and SIVmac239 gp120 glycoproteins to bind the CCR5 mutants. These results identify a region of CCR5 that is necessary for the physical association of the gp120 envelope glycoprotein with CCR5 and for HIV-1 infection.
1型人类免疫缺陷病毒(HIV-1)除了需要CD4外,还需要特定趋化因子受体的存在才能进入靶细胞。在感染的无症状阶段占主导地位的HIV-1巨噬细胞嗜性毒株会利用趋化因子受体CCR5。在此,我们鉴定出CCR5靠近N端半胱氨酸的一个富含酪氨酸的小区域,该区域对于HIV-1巨噬细胞嗜性和双嗜性变体的进入至关重要。与表达野生型CCR5的细胞感染相比,表达该区域发生变化的CCR5突变体的细胞被HIV-1感染的程度大幅降低。猿猴免疫缺陷病毒(SIVmac239)在这些突变体的一部分上进入也被消除,但在其他突变体上则增强。病毒进入的这些差异与可溶性、单体HIV-1和SIVmac239 gp120糖蛋白结合CCR5突变体的相对能力相关。这些结果确定了CCR5的一个区域,该区域对于gp120包膜糖蛋白与CCR5的物理结合以及HIV-1感染是必需的。